https://www.biospace.com/data-from-two-phase-3-studies-demonstrating-fitusiran-significantly-reduced-bleeds-in-people-with-hemophilia-a-or-b-with-or-without-inhibitors-were-featured-at-ash-s-plenary-and-late-breaking-sessions
Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with...
Dec 14, 2021 - Positive data from two Phase 3 studies evaluating the efficacy and safety of fitusiran, an investigational small interference RNA (siRNA) therapy for the...
https://www.buzzsprout.com/1564352/episodes/12547179-alok-srivastava-on-fitusiran-for-patients-with-haemophilia-a-and-b
Alok Srivastava on fitusiran for patients with haemophilia A and B
Professor Alok Srivastava tells us about two clinical trials being published in The Lancet and The Lancet Haematology on a new siRNA therapy called fitusiran...
alok srivastavafor patientsfitusiran